Placental transfer of albendazole sulphoxide enantiomers in sheep

Veterinary Journal

Volumn 163, Issue 2, 2002, Pages 155-160

  Capece, B P S ^a   Perez R ^b   Andaluz, A ^a   Perez F ^a   Garcia, F ^a   Castells, G ^a   Arboix, M ^a   Cristòfol, Carles ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b UNIVERSITY OF CONCEPCIÓN   (Chile)

Author keywords

Albendazole sulphoxide; Enantiomers; Fetus; Pregnancy; Sheep

Indexed keywords

ALBENDAZOLE SULFOXIDE; ANTHELMINTIC AGENT; OXIBENDAZOLE; RYCOBEN SC; SULFUR; VETERINARY DRUG; ALBENDAZOLE; DRUG DERIVATIVE;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; ATOM; CHEMICAL STRUCTURE; CHIRALITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG ADMINISTRATION ROUTE; DRUG BLOOD LEVEL; DRUG FORMULATION; EMBRYOTOXICITY; ENANTIOMER; FEMALE; MEAN RESIDENCE TIME; MOTHER; NONHUMAN; PLACENTAL TRANSFER; RACEMIC MIXTURE; SHEEP; TERATOGENICITY; THIRD TRIMESTER PREGNANCY; VETERINARY MEDICINE; ANIMAL; FETOMATERNAL TRANSFUSION; FETUS; GESTATIONAL AGE; METABOLISM; ORAL DRUG ADMINISTRATION; PLACENTA CIRCULATION; PREGNANCY; STEREOISOMERISM;

OVIS; OVIS ARIES;

ADMINISTRATION, ORAL; ALBENDAZOLE; ANIMALS; ANTHELMINTICS; AREA UNDER CURVE; FEMALE; FETUS; GESTATIONAL AGE; MATERNAL-FETAL EXCHANGE; PLACENTAL CIRCULATION; PREGNANCY; SHEEP; STEREOISOMERISM;

EID: 0036491246     PISSN: 10900233     EISSN: None     Source Type: Journal    
DOI: 10.1053/tvjl.2001.0628     Document Type: Article

References (30)

1. Benchaoui H. A. Scott E. W. McKellar Q. A. Pharmacokinetics of albendazole, albendazole sulfoxide and netobimin in goats Journal of Veterinary Pharmacology and Therapeutics 16 1993 237-240
2. Benoit E. Besse S. Delatour P. Effect of repeated doses of albendazole on enantiomerism of its sulfoxide metabolite in goats American Journal of Veterinary Research 53 1992 1663-1665
3. Berrozpe J. D. Lanas J. M. Pla-Delfina J. M. Biofarmacia y farmacocinética 1997 Editorial Síntesis S.A. Madrid p. 167-200
4. Bourget P. Roulot C. Fernandez H. Transfert transplacentaire et métabolisme foeto-placentaire des médicaments: méthodes détude, apports et implications thérapeutiques Therapie 49 1994 481-497
5. Capece B. P.S. Castells G. Pérez F. Arboix M. Cristòfol C. Pharmacokinetic behaviour of albendazole sulfoxide enantiomers in male and female sheep Veterinary Research Communications 24 2000 339-348
6. Cristofol C. Carretero A. Fernandez M. Navarro M. Sautet J. Ruberte J. Arboix M. Transplacental transport of netobimin metabolites in ewes European Journal of Drug Metabolism and Pharmacokinetics 20 1995 167-171
7. Cristofòl C. Navarro M. Franquelo C. Valladares J. E. Carretero A. Ruberte J. Arboix M. Disposition of netobimin, albendazol, and its metabolites in the pregnant rat: Developmental toxicity Toxicology and Applied Pharmacology 144 1997a 56-61
8. Cristofol C. Franquelo C. Navarro M. Carretero A. Ruberte J. Arboix M. Comparative pharmacokinetics of netobimin metabolites in pregnant ewes Research in Veterinary Science 62 1997b 117-120
9. Cristofol C. Virkel G. Alvarez L. Lanusse C. Intravenous Pharmacokinetics of albendazole sulfoxide enantiomers in cattle Fundamental and Clinical Pharmacology 13 1999 Suppl 1 375s
10. Delatour P. Garnier F. Benoit E. Longin C. H. A correlation of toxicity of albendazole and oxfendazole with their free metabolites and bound residues Journal of Veterinary Pharmacology and Therapeutics 7 1984 139-145
11. Delatour P. Benoit E. Garnier F. Besse S. Chirality of the sulphoxide of fenbendazole and albendazole in sheep Journal of Veterinary Pharmacology and Therapeutics 13 1990 361-366
12. Delatour P. Benoit E. Besse S. Boukra A. Comparative enantioselectivity in the sulfoxidation of albendazole in man, dogs and rats Xenobiotica 21 1991a 217-221
13. Delatour P. Garnier F. Benoit E. Caude I. Chiral behaviour of the metabolite albendazole sulphoxide in sheep, goats and cattle Research in Veterinary Science 50 1991b 134-138
14. 1-acid glycoprotein stationary phase Journal of Chromatography 619 1993 79-86
15. Fabre J. M. Berthelot X. Ferney J. Embryotoxicite des antiparasitaires chez les ovins: observation clinique Revue Médicine Vétérinaire 140 1989 1089-1095
16. Farrier D. S. PK Solutions (ver. 2.0.2): a Noncompartmental Pharmacokinetic Data Analysis program, Ashland, Ohio, Summit Research
17. Ingold K. Bigler P. Thormann W. Cavaliero T. Gottstein B. Hemphill A. Efficacies of albendazole sulfoxide and albendazole sulfone against in vitro-cultivated Echinococcus multilocularis metacestodes Antimicrobial Agents and Chemotherapy 43 1999 1050-1061
18. Lanchote V. L. Marques M. P.C. Takayanagui O. M. Carvalho R. Paias F. O. Bonato P. S. Simultaneous determination of albendazole sulfoxide enantiomers and albendazole sulfone in plasma Journal of Chromatography B 709 1998 273-279
19. Lanusse C. E. Virkel G. L. Sanchez S. F. Alvarez L. I. Lifschitz A. I. Imperiale F. Monfrinotti A. Ricobendazole kinetics and availability following subcutaneous administration of a novel injectable formulation to calves Research in Veterinary Science 39 1998 5-10
20. McKellar Q. A. Coop R. L. Jackson F. The pharmacokinetics of albendazole metabolites following administration of albendazole, albendazole sulfoxide and netobimin to one-month and eight-month-old sheep International Journal for Parasitology 25 1995 1207-1212
21. Mirkin B. L. Perinatal pharmacology: Placental transfer, fetal localization, and neonatal disposition of drugs Anesthesiology 43 1975 156-170
22. Moroni P. Buronfosse T. Longin-Sauvageon C. Delatour P. Benoit E. Chiral sulfoxidation of albendazole by the flavin adenine dinucleotide-containing and cytochrome P450-dependent monooxygenases from rat liver microsomes Drug Metabolism and Disposition 23 1995 160-165
23. Navarro M. Cristofol C. Carretero A. Arboix M. Ruberte J. Anthelmintic induced congenital malformations in sheep embryos using netobimin Veterinary Record 142 1998 86-90
24. Navarro M. Canut L. Carretero A. Cristofol C. Perez-Aparicio F. J. Arboix M. Ruberte J. Developmental toxicity in rat fetuses exposed to the benzimidazole netobimin Reproductive Toxicology 13 1999 295-302
25. Notarianni L. J. Plasma protein binding of drugs in pregnancy and in neonates Clinical Pharmacokinetics 18 1990 20-36
26. Perez R. Espinoza M. Riquelme R. Parer J. T. Llanos A. J. Arginine vasopressin mediates cardiovascular responses to hypoxemia in fetal sheep American Journal of Physiology 256 1989 R1011-18
27. Ridoux O. Drancourt M. In vitro susceptibilities of the microsporidia Encephalitozzon cuniculi, Encephalitozzon hellen, andEncephalitozzon intestinalis to albendazole and its sulfoxide and sulfone metabolites Antimicrobial Agents and Chemotherapy 42 1998 3301-3303
28. Solana H. Sallovitz J. M. Najle R. Rodriguez J. A. Lanusse C. E. Liver sulphoxidative metabolism of albendazole in rat: enantioselectivity and effect of methimazole Methods and Findings in Experimental and Clinical Pharmacology 22 2000 83-88
29. Tonn G. R. Doroudian A. Gordon J. G. Rurak D. W. Riggs K. W. Abbott F. S. Axelson J. E. New approaches for drug and kinetic analysis in the maternal-fetal unit NIDA Research Monograph 154 1995 175-202
30. Virkel G. Lifschitz A. Soraci A. Sansinanea A. Lanusse C. Enantioselective liver microsomal sulphoxidation of albendazole in cattle: effect of nutritional status Xenobiotica 30 2000 381-393